Paulina Skupin-Mrugalska

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Venues

International journal of molecular sciences

Pharmaceutics

Cancers

Molecules (Basel, Switzerland)

Poznan University of Medical Sciences

Poznan University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Poznan University of Medical Sciences Jan 01 2014

Poland

research assistant :: Department of Inorganic and Analytical Chemistry

Education History

Poznan University of Medical Sciences Oct 01 2009 - Dec 31 2013

Poland

PHD :: Department of Inorganic and Analytical Chemistry

Poznan University of Medical Sciences Oct 01 2003 - Mar 31 2009

Poland

MSC

Publications

Marta Kus-Slowinska, Klaudia Gorniak, Piotr Czaklosz, Anna Olejnik, Paulina Skupin-Mrugalska, Izabela Ibragimow, Hanna Piotrowska-Kempisty
Permeability of the Perindopril Arginine under In Vitro Conditions across Caco-2 Monolayer and Biomimetic Phospholipid Membrane. Molecules (Basel, Switzerland) 27 (7) (2022)
Patrycja Kłos, Magdalena Perużyńska, Magdalena Baśkiewicz-Hałasa, Paulina Skupin-Mrugalska, Małgorzata Anna Majcher, Magdalena Sawczuk, Bartosz Szostak, Marek Droździk, Bogusław Machaliński, Dariusz Chlubek
Response of Skin-Derived and Metastatic Human Malignant Melanoma Cell Lines to Thymoquinone and Thymoquinone-Loaded Liposomes. Pharmaceutics 14 (11) (2022)
Paulina Skupin-Mrugalska, Philipp A Elvang, Martin Brandl
Application of Asymmetrical Flow Field-Flow Fractionation for Characterizing the Size and Drug Release Kinetics of Theranostic Lipid Nanovesicles. International journal of molecular sciences 22 (19) (2021)
Andrzej Nowicki, Magdalena Kulus, Maria Wieczorkiewicz, Wojciech Pieńkowski, Katarzyna Stefańska, Paulina Skupin-Mrugalska, Rut Bryl, Paul E Mozdziak, Bartosz Kempisty, Hanna Piotrowska-Kempisty
Ovarian Cancer and Cancer Stem Cells-Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology. Cancers 13 (16) (2021)
Paulina Skupin-Mrugalska, Tamara Minko
Development of Liposomal Vesicles for Osimertinib Delivery to EGFR Mutation-Positive Lung Cancer Cells. Pharmaceutics 12 (10) (2020)
Andrzej Nowicki, Paulina Skupin-Mrugalska, Malgorzata Jozkowiak, Marcin Wierzchowski, Marcin Rucinski, Piotr Ramlau, Violetta Krajka-Kuzniak, Jadwiga Jodynis-Liebert, Hanna Piotrowska-Kempisty
The Effect of 3'-Hydroxy-3,4,5,4'-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian Cancer Cells. International journal of molecular sciences 21 (3) (2020)

Paulina Skupin-Mrugalska.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paulina Skupin-Mrugalska